Search company, investor...
Weavr Health company logo

Weavr Health

weavrhealth.com

Founded Year

2005

Stage

Series B | Alive

Total Raised

$21.88M

About Weavr Health

Weavr Health is dedicated to connecting people to health by simplifying sample collection and processing for healthcare.The Velvet device is designed so anyone, anywhere can easily collect high-quality samples without a phlebotomist. The Velvet device offers a smooth experience of blood self-collection for patients. It leverages a similar experience to traditional glucose testing, which >25% of people have experienced. Each device arrives with all that is needed to collect, package and ship quality samples to the lab for a convenient experience.

Headquarters Location

192 South Street Suite 20

Boston, Massachusetts, 02111,

United States

585-339-8582

Missing: Weavr Health's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Weavr Health's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Weavr Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Weavr Health is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

8,804 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

702 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

H

Health IT

7,901 items

Weavr Health Patents

Weavr Health has filed 1 patent.

The 3 most popular patent topics include:

  • Blood tests
  • Medical tests
  • Fluid dynamics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/18/2019

11/8/2022

Medical tests, Blood tests, Medical equipment, Laboratory equipment, Laboratory glassware

Grant

Application Date

10/18/2019

Grant Date

11/8/2022

Title

Related Topics

Medical tests, Blood tests, Medical equipment, Laboratory equipment, Laboratory glassware

Status

Grant

Latest Weavr Health News

HistoWiz Appoints Linh Hoang as CEO and Board Member

Oct 26, 2022

October 26, 2022 09:00 AM Eastern Daylight Time LONG ISLAND CITY, N.Y.--( BUSINESS WIRE )--HistoWiz, a leading provider of digital histopathology services to academia, biotech and pharma, announced today that Linh Hoang, MD, PhD has been appointed Chief Executive Officer and member of the Board of Directors. Dr. Hoang is joining HistoWiz from Weavr Health, where he served as CEO and Chairman of the Board of Directors. Prior to Weavr, Linh served as Vice President and General Manager of Reproductive Health Diagnostics at PerkinElmer. He has also held numerous leadership roles at Thermo Fisher Scientific, including General Manager of the clinical controls and standards business and Director for Life Technologies’ personalized medicine initiatives. He was previously a consultant at Boston Consulting Group. Linh received his medical and doctoral degrees from the University of Pennsylvania and holds a bachelor’s in biochemistry from the University of Florida. “On behalf of the Board, we are pleased to attract Dr. Hoang to the company as the company has nearly doubled revenue in the past year and is poised for continued growth as it furthers its leadership position in the digital pathology field,” said Joseph Siletto, Board Member from Vivo Capital. "We welcome Linh to the HistoWiz team with the confidence that he is not only an experienced operator, but also a strategic thinker to navigate this exciting and rapidly evolving field. We are grateful for our founder Dr. Ke Cheng’s leadership in establishing a strong foundation and look forward to her collaboration with Dr. Hoang both on the board of directors and the senior leadership team.” “I am proud to join HistoWiz’s accomplished team who has developed a differentiated platform to accelerate research and discovery,” said Dr. Hoang. “I’m looking forward to continuing to work with Dr. Ke Cheng in her role as President and Board Member. I am very excited to grow HistoWiz to lead the digital transformation in research histopathology and believe HistoWiz is well-positioned to become the market leader in histopathology services worldwide.” About HistoWiz HistoWiz automates histopathology with rapid turnaround times for researchers in academia, biotech and pharma. The company utilizes state-of-the-art technologies to process tissue specimens and host the digitized results on a proprietary platform, PathologyMapTM. Researchers use this advanced, online platform to manage their histology data and to collaborate with researchers across the world. With HistoWiz’s AI and proprietary tools, PathologyMap bridges researchers to a network of top pathologists for on-demand interpretation with industry-leading turnaround times. HistoWiz aims to become the global leader in histopathology to accelerate research and discovery. Contacts

Weavr Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Weavr Health Rank

Weavr Health Frequently Asked Questions (FAQ)

  • When was Weavr Health founded?

    Weavr Health was founded in 2005.

  • Where is Weavr Health's headquarters?

    Weavr Health's headquarters is located at 192 South Street, Boston.

  • What is Weavr Health's latest funding round?

    Weavr Health's latest funding round is Series B.

  • How much did Weavr Health raise?

    Weavr Health raised a total of $21.88M.

  • Who are the investors of Weavr Health?

    Investors of Weavr Health include Paycheck Protection Program, LabCorp, Anzu Partners and Boston University Technology Development.

  • Who are Weavr Health's competitors?

    Competitors of Weavr Health include Visby Medical, Baebies, Cardea Bio, MeMed, Accellix, Inflammatix, Oxford Nanopore Technologies, LumiraDx, Cue Health, Roche Holding and 22 more.

Compare Weavr Health to Competitors

Inflammatix Logo
Inflammatix

Inflammatix is a molecular diagnostics company that develops rapid tests that read the immune system to resolve major clinical and public health challenges. The company's initial focus is on acute bacterial, viral infections, and sepsis.

Torus Biosystems Logo
Torus Biosystems

Torus Biosystems develops a syndromic diagnostic device designed for use in testing DNA for scientific and medical research purposes. Its Torus Synestia System provides seamless, comprehensive, sample-to-insight test results for major infectious diseases in a faster format than conventional methods, helping for better patient care and improved outcomes. The company was founded in 2019 and is based in Cambridge, Massachusetts.

S
Sight Diagnostics

Sight Diagnostics provides affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Its proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.

Ellume Logo
Ellume

Ellume is a digital diagnostics company that develops and commercializes connected products for healthcare professionals and consumers. The company has developed a new biosensor technology that features unique optoelectronics and biologics.

Binx Health Logo
Binx Health

Binx Health is an in vitro diagnostics Point-of-Care (POC) company that provides at-home STI testing. The platform also includes evidence-based testing, counseling, treatment, and follow up in order to increase screening and reduce infections.

Baebies Logo
Baebies

Baebies developed a nimble bioassay automation platform to rapidly perform multiplex enzymatic assays and other tests. The company licensed its core technology, digital microfluidics, from Illumina. In addition to a technology license in newborn screening that does not include sequencing, Baebies also received equipment, contracts, and other consideration in exchange for a share of ownership in the new company. The company was founded in 2013 and is based in Durham, North Carolina.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.